The combination of JQ1 and cisplatin further enhanced the effects of BET inhibition in JQ1-sensitive cells, while promoting apoptosis and reducing tumor growth in cells that showed a poor response to JQ1 alone. This evidence concerns the gene DNER and neoplasm.